A New Frontier in Diabetes Care, But at What Cost? The FDA's approval of Mounjaro to lower cardiovascular risks in adults with Type 2 diabetes marks a significant milestone in the treatment of this chronic condition.
Researchers have been searching for ways to mitigate the devastating impact of heart disease on people living with diabetes.
Approximately 40 million Americans suffer from Type 2 diabetes, and heart disease is the leading cause of death among them.